Literature DB >> 19442733

Dendritic spine pathologies in hippocampal pyramidal neurons from Rett syndrome brain and after expression of Rett-associated MECP2 mutations.

Christopher A Chapleau1, Gaston D Calfa, Meredith C Lane, Asher J Albertson, Jennifer L Larimore, Shinichi Kudo, Dawna L Armstrong, Alan K Percy, Lucas Pozzo-Miller.   

Abstract

Rett syndrome (RTT) is an X chromosome-linked neurodevelopmental disorder associated with the characteristic neuropathology of dendritic spines common in diseases presenting with mental retardation (MR). Here, we present the first quantitative analyses of dendritic spine density in postmortem brain tissue from female RTT individuals, which revealed that hippocampal CA1 pyramidal neurons have lower spine density than age-matched non-MR female control individuals. The majority of RTT individuals carry mutations in MECP2, the gene coding for a methylated DNA-binding transcriptional regulator. While altered synaptic transmission and plasticity has been demonstrated in Mecp2-deficient mouse models of RTT, observations regarding dendritic spine density and morphology have produced varied results. We investigated the consequences of MeCP2 dysfunction on dendritic spine structure by overexpressing ( approximately twofold) MeCP2-GFP constructs encoding either the wildtype (WT) protein, or missense mutations commonly found in RTT individuals. Pyramidal neurons within hippocampal slice cultures transfected with either WT or mutant MECP2 (either R106W or T158M) showed a significant reduction in total spine density after 48 h of expression. Interestingly, spine density in neurons expressing WT MECP2 for 96 h was comparable to that in control neurons, while neurons expressing mutant MECP2 continued to have lower spine density than controls after 96 h of expression. Knockdown of endogenous Mecp2 with a specific small hairpin interference RNA (shRNA) also reduced dendritic spine density, but only after 96 h of expression. On the other hand, the consequences of manipulating MeCP2 levels for dendritic complexity in CA3 pyramidal neurons were only minor. Together, these results demonstrate reduced dendritic spine density in hippocampal pyramidal neurons from RTT patients, a distinct dendritic phenotype also found in neurons expressing RTT-associated MECP2 mutations or after shRNA-mediated endogenous Mecp2 knockdown, suggesting that this phenotype represent a cell-autonomous consequence of MeCP2 dysfunction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19442733      PMCID: PMC2722110          DOI: 10.1016/j.nbd.2009.05.001

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  77 in total

Review 1.  Dendritic spine formation and pruning: common cellular mechanisms?

Authors:  I Segal; I Korkotian; D D Murphy
Journal:  Trends Neurosci       Date:  2000-02       Impact factor: 13.837

2.  Effects of Rett syndrome mutations of the methyl-CpG binding domain of the transcriptional repressor MeCP2 on selectivity for association with methylated DNA.

Authors:  E Ballestar; T M Yusufzai; A P Wolffe
Journal:  Biochemistry       Date:  2000-06-20       Impact factor: 3.162

3.  Functional consequences of Rett syndrome mutations on human MeCP2.

Authors:  T M Yusufzai; A P Wolffe
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

4.  Multicolor "DiOlistic" labeling of the nervous system using lipophilic dye combinations.

Authors:  W B Gan; J Grutzendler; W T Wong; R O Wong; J W Lichtman
Journal:  Neuron       Date:  2000-08       Impact factor: 17.173

5.  LTD induction causes morphological changes of presynaptic boutons and reduces their contacts with spines.

Authors:  Nadine Becker; Corette J Wierenga; Rosalina Fonseca; Tobias Bonhoeffer; U Valentin Nägerl
Journal:  Neuron       Date:  2008-11-26       Impact factor: 17.173

6.  MECP2 is highly mutated in X-linked mental retardation.

Authors:  P Couvert; T Bienvenu; C Aquaviva; K Poirier; C Moraine; C Gendrot; A Verloes; C Andrès; A C Le Fevre; I Souville; J Steffann; V des Portes; H H Ropers; H G Yntema; J P Fryns; S Briault; J Chelly; B Cherif
Journal:  Hum Mol Genet       Date:  2001-04-15       Impact factor: 6.150

Review 7.  Dendritic anomalies in disorders associated with mental retardation.

Authors:  W E Kaufmann; H W Moser
Journal:  Cereb Cortex       Date:  2000-10       Impact factor: 5.357

8.  Dendritic cytoskeletal protein expression in mental retardation: an immunohistochemical study of the neocortex in Rett syndrome.

Authors:  W E Kaufmann; S M MacDonald; C R Altamura
Journal:  Cereb Cortex       Date:  2000-10       Impact factor: 5.357

Review 9.  From form to function: calcium compartmentalization in dendritic spines.

Authors:  R Yuste; A Majewska; K Holthoff
Journal:  Nat Neurosci       Date:  2000-07       Impact factor: 24.884

10.  Evidence for both neuronal cell autonomous and nonautonomous effects of methyl-CpG-binding protein 2 in the cerebral cortex of female mice with Mecp2 mutation.

Authors:  Nadia P Belichenko; Pavel V Belichenko; William C Mobley
Journal:  Neurobiol Dis       Date:  2009-01-08       Impact factor: 5.996

View more
  103 in total

1.  HDAC activity is required for BDNF to increase quantal neurotransmitter release and dendritic spine density in CA1 pyramidal neurons.

Authors:  Gaston Calfa; Christopher A Chapleau; Susan Campbell; Takafumi Inoue; Sarah J Morse; Farah D Lubin; Lucas Pozzo-Miller
Journal:  Hippocampus       Date:  2011-12-07       Impact factor: 3.899

Review 2.  Brain-derived neurotrophic factor and neuropsychiatric disorders.

Authors:  Anita E Autry; Lisa M Monteggia
Journal:  Pharmacol Rev       Date:  2012-03-08       Impact factor: 25.468

3.  Normal mitral cell dendritic development in the setting of Mecp2 mutation.

Authors:  A M Palmer; A L Degano; M J Park; S Ramamurthy; G V Ronnett
Journal:  Neuroscience       Date:  2011-11-28       Impact factor: 3.590

Review 4.  The role of MeCP2 in CNS development and function.

Authors:  Elisa S Na; Lisa M Monteggia
Journal:  Horm Behav       Date:  2010-05-31       Impact factor: 3.587

5.  A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells.

Authors:  Maria C N Marchetto; Cassiano Carromeu; Allan Acab; Diana Yu; Gene W Yeo; Yangling Mu; Gong Chen; Fred H Gage; Alysson R Muotri
Journal:  Cell       Date:  2010-11-12       Impact factor: 41.582

Review 6.  Altered trajectories of neurodevelopment and behavior in mouse models of Rett syndrome.

Authors:  Elizabeth S Smith; Dani R Smith; Charlotte Eyring; Maria Braileanu; Karen S Smith-Connor; Yew Ei Tan; Amanda Y Fowler; Gloria E Hoffman; Michael V Johnston; Sujatha Kannan; Mary E Blue
Journal:  Neurobiol Learn Mem       Date:  2018-11-29       Impact factor: 2.877

7.  Acute and crucial requirement for MeCP2 function upon transition from early to late adult stages of brain maturation.

Authors:  Fang Du; Minh Vu Chuong Nguyen; Ariel Karten; Christy A Felice; Gail Mandel; Nurit Ballas
Journal:  Hum Mol Genet       Date:  2016-02-16       Impact factor: 6.150

Review 8.  Rett syndrome: exploring the autism link.

Authors:  Alan K Percy
Journal:  Arch Neurol       Date:  2011-08

Review 9.  Experimental models of Rett syndrome based on Mecp2 dysfunction.

Authors:  Gaston Calfa; Alan K Percy; Lucas Pozzo-Miller
Journal:  Exp Biol Med (Maywood)       Date:  2011-01

10.  Loss of MeCP2 in immature neurons leads to impaired network integration.

Authors:  Yi Sun; Yu Gao; Joseph J Tidei; Minjie Shen; Johnson T Hoang; Daniel F Wagner; Xinyu Zhao
Journal:  Hum Mol Genet       Date:  2019-01-15       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.